Gossamer Bio (GOSS) Operating Margin (2022 - 2025)
Historic Operating Margin for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to 369.44%.
- Gossamer Bio's Operating Margin fell 116500.0% to 369.44% in Q3 2025 from the same period last year, while for Sep 2025 it was 802.08%, marking a year-over-year decrease of 7329400.0%. This contributed to the annual value of 66.06% for FY2024, which is N/A changed from last year.
- Latest data reveals that Gossamer Bio reported Operating Margin of 369.44% as of Q3 2025, which was down 116500.0% from 337.41% recorded in Q2 2025.
- Gossamer Bio's 5-year Operating Margin high stood at 1612.12% for Q3 2022, and its period low was 372.23% during Q1 2025.
- Over the past 4 years, Gossamer Bio's median Operating Margin value was 247.08% (recorded in 2024), while the average stood at 593.99%.
- Examining YoY changes over the last 5 years, Gossamer Bio's Operating Margin showed a top increase of -116500bps in 2025 and a maximum decrease of -3917600bps in 2025.
- Gossamer Bio's Operating Margin (Quarter) stood at 1572.37% in 2022, then dropped by -13bps to 1369.77% in 2023, then crashed by -82bps to 247.08% in 2024, then crashed by -250bps to 369.44% in 2025.
- Its Operating Margin was 369.44% in Q3 2025, compared to 337.41% in Q2 2025 and 372.23% in Q1 2025.